medigraphic.com
Federación Mexicana de Ginecología y Obstetricia, A.C.

2010, Número 05

<< Anterior

Ginecol Obstet Mex 2010; 78 (05)


Guías de práctica clínica. Infección recurrente en las vías urinarias de la mujer

Velázquez MP, Romero-Nava LE, López ÁDR, Quiroz-Garza G

Idioma: Español
Referencias bibliográficas: 60
Paginas: 437-459
Archivo PDF: 600.54 Kb.


RESUMEN

Introducción: la infección de las vías urinarias es la segunda causa de prescripción empírica de antibióticos. Es más frecuente en la mujer sexualmente activa y con enfermedades asociadas. Cuando se padecen más de tres episodios por año, se cataloga como recurrente; el diagnóstico debe realizarse con urocultivos, y de acuerdo con la evaluación individual se orientará el tratamiento que incluya la profilaxis a largo plazo.
Objetivo: desarrollar una guía clínica para el diagnóstico y tratamiento de la infección recurrente de vías urinarias en la mujer, resaltar la evidencia de la sensibilidad y la resistencia bacteriana a los antibióticos en México.
Material y métodos: describir las opciones de tratamiento antibiótico con base en la etiología y sensibilidad, con insistencia en las opciones de prevención y profilaxis.
Resultados: se obtuvieron criterios homogéneos de diagnóstico y tratamiento en las mujeres con infección recurrente de las vías urinarias y para disminuir los episodios, la morbilidad asociada y la resistencia bacteriana.
Conclusiones: se efectuó una revisión sistemática de las investigaciones clínicas de diagnóstico y tratamiento de la infección recurrente de las vías urinarias. La calidad de la evidencia está relacionada con la aplicación de los criterios descritos en el esquema de Oxford modificado.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Barclay L. New Guidelines for Management of Urinary Tract Infection in Nonpregnant Women. Obstet Gynecol 2008;111:785-794.

  2. Schaeffer AJ. Infection of the urinary tract. Walsh PC, editor. Cambell’s Urology, 8th ed. Philadelphia: Saunders, 2002;p:515-602.

  3. Valdevenito SJP. Recurrent urinary tract infection in women. Rev Chil Infect 2008;25(4):268-276.

  4. Foxman B. Recurring urinary tract infection: incidence and risk factors. Am J Public Health 1990;80:331-333.

  5. Anderson GG, Palermo JJ, Schilling JD, et al. Intracellular bacterial biofilm-like pods in urinary tract infections. Science 2003;301:105-107.

  6. Anderson GG, Dodson KW, Hooton TM, Hultgren SJ. Intracellular bacterial communities of uropathogenic Escherichia coli in urinary tract pathogenesis. Trends Microbiol 2004;12:424-430.

  7. Ochoa SC, Eiros BJM, Pérez MCL, y cols. Etiología de las infecciones del tracto urinario y sensibilidad de los uropatógenos a los antimicrobianos. Rev Esp Quimioterap 2005;18(2):124-135.

  8. Finer G, Landau D. Pathogenesis of urinary tract infections with normal female anatomy. Lancet Infect Dis 2004;4:631-635.

  9. Svanborg C, Goldaly G. Bacterial virulence in urinary tract infection. Infect Dis Clin North Am 1997;11:513-529.

  10. Romero NLE, Rodríguez CS, Velázquez SMP, Rasch JR. Low urinary tract infection and cystoscopic findings in Urogynecology Service in the Instituto Nacional de Perinatología. Ginecol Obstet Mex 2003;71:508-514.

  11. Guidelines & Protocols. Avisory Committee. Urinary Tract Infections-Macroscopic and Microscopic Urinalysis and Investigation of Urinary Tract Infections. British Columbia Medical Association. Ministry of Health. Website: .

  12. Lawrentschuk N, Ooi J, Pang A, et al. Cystoscopy in women with recurrent urinary tract infection. Int J Urol 2006;13(4):350-353.

  13. Fair WR, Mcclennan BL, Jost RG. Are excretory urograms necessary in evaluating women with urinary tract infection? J Urol 1979;121:313-315.

  14. Curtis N. Management of urinary tract infections: historical perspective and current strategies: part 2. Modern Management. J Urol 2005;173:27-32.

  15. Engel G, Schaeffer AJ, Grayhack JT, Wendel EF. The role of excretory urography and cystoscopy in the evaluation and management of women with recurrent urinary tract infection. J Urol 1980;123:190-191.

  16. Fowler JE, Pulaski ET. Excretory urography, cystography, and cystoscopy in the evaluation of women with urinary-tract infection. A prospective study. N Engl J Med 1981;304:462-465.

  17. Fairchild TN, Shuman W, Berger RE. Radiographic studies for women with recurrent urinary tract infections. J Urol 1982;128:344-345.

  18. Clinical Knowledge Summaries Chlamydia, uncomplicated, genital (women). Last revised in May 2006.

  19. Burkhard FC, Blick N, Hochreiter WW, Studer UE. Urinary urgency and frequency, and chronic urethral and/or pelvic pain in females. Can doxycycline help? J Urol 2004;172(1):232-235.

  20. Hooton TM. Pathogenesis of urinary tract infections: an update. J Antimicrob Chemother 2000;46(Suppl. 1):1-7; discussion 63-65.

  21. Ena J, Arjona F, Martínez-Peinado C, et al. Epidemiology of urinary tract infections caused by extended-spectrum beta-lactamase-producing Escherichia coli. Urology 2006;68:1169-1174.

  22. Arredondo GJL, et al. Resistance of uropathogenic bacteria to first-line antibiotics in Mexico City: a multicenter, susceptibility analysis. Curr Ther Res Clin Exp 2007;68.

  23. Milo G, Katchman E, Paul M, et al. Duration of antibacterial treatment for uncomplicated urinary tract infection in women. Cochrane Database of Systematic Reviews 2005, Issue 2. Art. No.: CD004682. DOI: 10.1002/14651858.CD004682.pub2.

  24. Warren JW, Abrutyn E, Hebel R, et al. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and pyelonephritis in women. Clin Infect Dis 1999;29:745-748.

  25. Rafalsky VV, Andreeva IV, Rjabkova EL. Quinolones for uncomplicated acute cystitis in women. Cochrane Database of Systematic Reviews 2006, Issue 3. Art. No.: CD003597. DOI:10.1002/14651858.CD003597.pub2.

  26. Hernández MS, García JA, Muñoz JL. In vitro activity of fosfomycin against ESBL-producing enterobacteria of urinary origin. Rev Esp Quimioter 2009;22(1):25-29.

  27. Bergogne BE. Lower urinary tract infections: bacterial epidemiology and recommendations Prog Urol 2008;18(1 Suppl. FMC):F11-14.

  28. Mozdzan M, Loba J, Ruxer J, Markuszewski L. Fosfomycin in the treatment of recurrent tract infections in type 2 diabetic patients. Pol Arch Med Wewn 2006;115(3):219-226.

  29. Katchman EA, Milo G, Paul M, et al. Three-day vs. longer duration of antibiotic treatment for cystitis in women: systematic review and meta-analysis. Am J Med 2005;118(11):1196-1207.

  30. Curtis JN. FRCSC Practical management of recurrent urinary tract infections in premenopausal women. Rev Urol 2005;7(1):11-17.

  31. Dwyer PL, O’Reilly M. Recurrent urinary tract infection in the female. Curr Opin Obstet Gynecol 2002;14:537-543.

  32. Czaja Ch, Hooton T. Update on acute uncomplicated urinary tract infection in women. Postgrad Med 2006;(1):1119. (On line).

  33. Sen A. Recurrent cystitis in non-pregnant women. Clin Evid 2008;2008. pii: 0801. (Online)

  34. Alexiou Z, Mouktaroudi M, Koratzanis G, et al. The significance of compliance for the success of antimicrobial prophylaxis in recurrent lower urinary tract infections: the Greek experience. Int J Antimicrob Agents 2007;30(1):40-43.

  35. Raz R. Hormone replacement therapy or prophylaxis in postmenopausal women with recurrent urinary tract infection. J Infect Dis 2001;183(Suppl. 1):S74-S76.

  36. Albert X, Huertas I, Pereiro I, et al. Antibiotics for preventing recurrent urinary tract infection in non-pregnant women. Cochrane Database of Systematic Reviews 2007, Issue 1. Art. No.: CD001209. DOI: 10.1002/14651858.CD001209.pub2.

  37. Kraft JK, Stamey TA. The natural history of symptomatic recurrent bacteriuria in women. Medicine (Baltimore) 1977;56:55-60.

  38. Brumfitt W, Hamilton-Miller JMT. Efficacy and safety profile of long term nitrofurantoin in urinary tract infection: 18 year’s experience. J Antimicrob Chemother 1998;42:363-371.

  39. Holmberg L, Boman G, Böttiger LE, et al. Adverse reactions to nitrofurantoin. Analysis of 921 reports. Am J Med 1980;69:733-738.

  40. Stapleton A, Latham RH, Johnson C, Stamm WE. Postcoital antimicrobial prophylaxis for recurrent urinary tract infection. JAMA 1990;264:703-706.

  41. Melekos MD, Asbach HW, Gerharz E, et al. Post-intercourse versus daily ciprofloxacin prophylaxis for recurrent urinary tract infections in premenopausal women. J Urol 1997;157:935-939.

  42. Brumfitt W, Hamilton-Miller JM. Efficacy and safety profile of long-term nitrofurantoin in urinary infections: 18 years’ experience. J Antimicrob Chemother 1998;42(3):363-371.

  43. Hooton TM. Recurrent urinary tract infection in women. Int J Antimicrob Agents 2001;17:259-268.

  44. U.S. Preventive Services Task Force. Screening for chlamydial infection: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2007;147:128-134.

  45. Rudenko N, Dorofeyev A. Prevention of recurrent lower urinary tract infections by long-term administration of fosfomycin trometamol. Double blind, randomized, parallel group, placebo controlled study. Arzneimittelforschung 2005;55(7):420-427.

  46. Chew LD, Fihn SD. Recurrent cystitis in nonpregnant women. West J Med 1999;170(5):274-277.

  47. UMHS Urinary Tract Infection Guideline, May 2005, University of Michigan. Guidelines for Health System Clinical Care Urinary Tract Infection. Taubman Medical Library .

  48. Cardozo L, Lose G, McClish D, et al. A systematic review of estrogens for recurrent urinary tract infections: third report of the hormones and urogenital therapy (HUT) committee. Int Urogynecol J Pelvic Floor Dysfunct 2001;12(1):15-20.

  49. Shawna L, Johnston SL, Farrell SA, et al. MD, FRCSC, Halifax NS. SCOG Clinical Practice Guidelines. The detection and management of vaginal atrophy. J Obstet Gynaecol Can 2004;26(5):503-508.

  50. Rozenberg S, Pastijn A, Gevers R, Murillo D. Estrogen therapy in older patients with recurrent urinary tract infections: a review. Int J Fertil Womens Med 2004;49(2):71-74.

  51. Robinson D, Cardozo LD. The role of estrogens in female lower urinary tract dysfunction. Urology 2003;62(4 Suppl. 1):45-51.

  52. Zafriri D, Ofek I, Adar R, et al. Inhibitory activity of cranberry juice on adherence of type 1 and type P fimbriated Escherichia coli to eukaryotic cells. Antimicrob Agents Chemother 1989;33:92-98.

  53. McMurdo ME, Bissett LY, Price RJ, et al. Does ingestion of cranberry juice reduce symptomatic urinary tract infections in older people in hospital? A double-blind, placebo-controlled trial. Age Ageing 2005;34(3):256-261.

  54. Kontiokari T, Laitinen J, Jarvi L, et al. Dietary factors protecting women from urinary tract infection. Am J Clin Nutr 2003;77(3):600-604.

  55. Franco AV. Recurrent urinary tract infections. Best Pract Res Clin Obstet Gynaecol 2005;19(6):861-873.

  56. Guay DR. Cranberry and urinary tract infections. Drugs 2009;69(7):775-807.

  57. Schmidt DR, Sobota AE. An examination of the anti-adherence activity of cranberry juice on urinary and nonurinary bacterial isolates. Microbios 1988;55:173-181.

  58. Howell A B, Foxman B. Cranberry juice and adhesion of antibiotic-resistant uropathogens. JAMA 2002;287:3082-3083.

  59. Baerheim A, Larsen E, Digranes A. Vaginal application of lactobacilli in the prophylaxis of recurrent lower urinary tract infection in women. Scand J Prim Health Care 1994;12(4):239-243.

  60. Baeur HW, Rahlfs VW, Lauener PA, Blessmann GSS. Prevention of recurrent urinary tract infections with immuno-active E. coli fractions: a meta-analysis of five placebo-controlled double-blind studies. Int J Antimicrob Agents 2002;19:451-456.




2020     |     www.medigraphic.com